Avinger (AVGR) Competitors $0.78 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends AVGR vs. AEMD, INBS, STSS, AFIB, NUWE, SONX, QNRX, POAI, VERO, and HSCSShould you be buying Avinger stock or one of its competitors? The main competitors of Avinger include Aethlon Medical (AEMD), Intelligent Bio Solutions (INBS), Sharps Technology (STSS), Acutus Medical (AFIB), Nuwellis (NUWE), Sonendo (SONX), Quoin Pharmaceuticals (QNRX), Predictive Oncology (POAI), Venus Concept (VERO), and Heart Test Laboratories (HSCS). These companies are all part of the "medical equipment" industry. Avinger vs. Aethlon Medical Intelligent Bio Solutions Sharps Technology Acutus Medical Nuwellis Sonendo Quoin Pharmaceuticals Predictive Oncology Venus Concept Heart Test Laboratories Avinger (NASDAQ:AVGR) and Aethlon Medical (NASDAQ:AEMD) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, community ranking, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership. Which has higher valuation & earnings, AVGR or AEMD? Aethlon Medical has lower revenue, but higher earnings than Avinger. Aethlon Medical is trading at a lower price-to-earnings ratio than Avinger, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvinger$7.65M0.23-$18.32M-$12.16-0.06Aethlon Medical$570K9.41-$12.21M-$3.84-0.10 Does the MarketBeat Community favor AVGR or AEMD? Avinger received 176 more outperform votes than Aethlon Medical when rated by MarketBeat users. Likewise, 57.71% of users gave Avinger an outperform vote while only 52.42% of users gave Aethlon Medical an outperform vote. CompanyUnderperformOutperformAvingerOutperform Votes39357.71% Underperform Votes28842.29% Aethlon MedicalOutperform Votes21752.42% Underperform Votes19747.58% Does the media prefer AVGR or AEMD? In the previous week, Avinger had 1 more articles in the media than Aethlon Medical. MarketBeat recorded 1 mentions for Avinger and 0 mentions for Aethlon Medical. Aethlon Medical's average media sentiment score of 0.50 beat Avinger's score of 0.00 indicating that Aethlon Medical is being referred to more favorably in the news media. Company Overall Sentiment Avinger Neutral Aethlon Medical Positive Which has more risk & volatility, AVGR or AEMD? Avinger has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500. Comparatively, Aethlon Medical has a beta of 1.74, indicating that its stock price is 74% more volatile than the S&P 500. Do institutionals & insiders have more ownership in AVGR or AEMD? 18.3% of Avinger shares are owned by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are owned by institutional investors. 13.0% of Avinger shares are owned by company insiders. Comparatively, 1.1% of Aethlon Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is AVGR or AEMD more profitable? Aethlon Medical has a net margin of 0.00% compared to Avinger's net margin of -260.86%. Avinger's return on equity of 0.00% beat Aethlon Medical's return on equity.Company Net Margins Return on Equity Return on Assets Avinger-260.86% N/A -117.86% Aethlon Medical N/A -141.89%-107.12% Do analysts rate AVGR or AEMD? Avinger currently has a consensus target price of $5.00, indicating a potential upside of 541.03%. Aethlon Medical has a consensus target price of $7.00, indicating a potential upside of 1,719.95%. Given Aethlon Medical's higher possible upside, analysts clearly believe Aethlon Medical is more favorable than Avinger.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avinger 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Aethlon Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryAvinger and Aethlon Medical tied by winning 8 of the 16 factors compared between the two stocks. Ad Porter & CompanyNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. Get Avinger News Delivered to You Automatically Sign up to receive the latest news and ratings for AVGR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVGR vs. The Competition Export to ExcelMetricAvingerSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.79M$4.45B$5.40B$8.53BDividend YieldN/A42.37%5.15%4.14%P/E Ratio-0.0637.84113.7615.14Price / Sales0.2364.751,483.0493.53Price / CashN/A49.2739.7134.04Price / Book-0.174.214.665.01Net Income-$18.32M$11.52M$119.06M$225.46M7 Day Performance-6.02%1.05%0.79%0.37%1 Month Performance-25.00%0.94%5.65%3.57%1 Year Performance-79.26%39.40%36.80%29.42% Avinger Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVGRAvinger2.8848 of 5 stars$0.78flat$5.00+541.0%-77.7%$1.79M$7.65M-0.0670Upcoming EarningsAnalyst ForecastAEMDAethlon Medical2.7883 of 5 stars$0.38+1.3%$7.00+1,742.6%-73.5%$5.28M$570,000.00-0.1010Analyst ForecastNews CoverageINBSIntelligent Bio Solutions0.4422 of 5 stars$1.59+1.9%N/A-51.7%$4.96M$3.11M-0.0410News CoverageGap DownSTSSSharps Technology1.131 of 5 stars$2.75+1.1%N/AN/A$4.95MN/A-0.263News CoverageAFIBAcutus MedicalN/A$0.16-2.5%N/A-69.4%$4.61M$7.16M0.00340NUWENuwellis2.243 of 5 stars$2.08+11.8%$17.00+717.3%-94.6%$3.89M$8.86M-0.0159News CoverageSONXSonendo1.3946 of 5 stars$0.05-8.0%$1.88+3,976.1%-84.1%$3.85M$43.87M-0.10250QNRXQuoin Pharmaceuticals3.1494 of 5 stars$0.88+8.8%$4.00+355.1%-81.9%$3.50MN/A-0.164News CoveragePOAIPredictive Oncology2.4976 of 5 stars$0.84+0.0%$3.00+258.8%-78.3%$3.43M$1.75M-0.2530Gap UpVEROVenus ConceptN/A$0.43-6.1%N/A-77.1%$3.12M$76.35M-0.05410Positive NewsGap UpHSCSHeart Test Laboratories3.217 of 5 stars$3.06-1.3%$15.00+390.2%-87.4%$2.01M$18,600.00-0.1410Positive News Related Companies and Tools Related Companies Aethlon Medical Alternatives Intelligent Bio Solutions Alternatives Sharps Technology Alternatives Acutus Medical Alternatives Nuwellis Alternatives Sonendo Alternatives Quoin Pharmaceuticals Alternatives Predictive Oncology Alternatives Venus Concept Alternatives Heart Test Laboratories Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AVGR) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avinger, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avinger With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
